<p>Listen to the Experts Discuss the Relevance of Rationality of the combination of SGLT2i and DPP-4i combinations.</p>

Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin | Dr. Debmalya Sanyal & Dr. Mahuya Sikdar

Listen to Endocrinologist and Diabetologist discuss the benefits of Empagliflozin &amp; Linagliptin usage in T2D management. This discussion will help clinicians to make informed decisions regarding the management of T2D using novel therapy of Empagliflozin &amp; Linagliptin.